MNX Launches Futures on AI Lab IPOs and Revenue

This is a notable expansion of what can be synthetically traded: pre-IPO AI exposure without equity, which matters most to traders seeking early positioning and to the labs themselves as a new price signal. The design is the real story — settlement tied to filings, private valuations or revenue estimates means the contract's value depends on definitions and verification, not a public market. Whether these benchmarks prove robust enough to anchor leveraged positions, and how they behave around an actual listing, is the open question.